Urinary tract infections in women

Sean P. McLaughlin, Culley C. Carson

Research output: Contribution to journalReview article

  • 33 Citations

Abstract

Urinary tract infections in female patients are exceedingly common. One third of all women with an initial UTI demonstrate recurrence, and one third of those recurrences are in the first 6 months. The potential morbidity of RUTIs is high, especially in infants, the elderly, and pregnant patients. Uropathogenic bacteria reside in the rectal vault, colonize the vagina, and then ascend per the urethra into the bladder. These bacteria avidly adhere to uroepithelial cells using pili and can further ascend to the kidneys. Empiric treatment of an initial uncomplicated UTI is acceptable, but recurrences warrant a urine culture and possible radiographic evaluation. Fluoroquinolones are now first-line medications for UTIs, except in geographic areas where resistance to TMP-SMX is still low. Response to therapy should govern the need for additional treatment. Certain motivated patients with three or more UTIs per year should be considered for prophylaxis therapy.

LanguageEnglish (US)
Pages417-429
Number of pages13
JournalMedical Clinics of North America
Volume88
Issue number2
DOIs
StatePublished - Jan 1 2004
Externally publishedYes

Fingerprint

Urinary Tract Infections
Recurrence
Bacteria
Fluoroquinolones
Sulfamethoxazole Drug Combination Trimethoprim
Vagina
Urethra
Therapeutics
Urinary Bladder
Urine
Morbidity
Kidney

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Urinary tract infections in women. / McLaughlin, Sean P.; Carson, Culley C.

In: Medical Clinics of North America, Vol. 88, No. 2, 01.01.2004, p. 417-429.

Research output: Contribution to journalReview article

McLaughlin, Sean P. ; Carson, Culley C./ Urinary tract infections in women. In: Medical Clinics of North America. 2004 ; Vol. 88, No. 2. pp. 417-429
@article{ed23165809864abc9eb3c59e00e93afd,
title = "Urinary tract infections in women",
abstract = "Urinary tract infections in female patients are exceedingly common. One third of all women with an initial UTI demonstrate recurrence, and one third of those recurrences are in the first 6 months. The potential morbidity of RUTIs is high, especially in infants, the elderly, and pregnant patients. Uropathogenic bacteria reside in the rectal vault, colonize the vagina, and then ascend per the urethra into the bladder. These bacteria avidly adhere to uroepithelial cells using pili and can further ascend to the kidneys. Empiric treatment of an initial uncomplicated UTI is acceptable, but recurrences warrant a urine culture and possible radiographic evaluation. Fluoroquinolones are now first-line medications for UTIs, except in geographic areas where resistance to TMP-SMX is still low. Response to therapy should govern the need for additional treatment. Certain motivated patients with three or more UTIs per year should be considered for prophylaxis therapy.",
author = "McLaughlin, {Sean P.} and Carson, {Culley C.}",
year = "2004",
month = "1",
day = "1",
doi = "10.1016/S0025-7125(03)00148-2",
language = "English (US)",
volume = "88",
pages = "417--429",
journal = "Medical Clinics of North America",
issn = "0025-7125",
publisher = "W.B. Saunders Ltd",
number = "2",

}

TY - JOUR

T1 - Urinary tract infections in women

AU - McLaughlin,Sean P.

AU - Carson,Culley C.

PY - 2004/1/1

Y1 - 2004/1/1

N2 - Urinary tract infections in female patients are exceedingly common. One third of all women with an initial UTI demonstrate recurrence, and one third of those recurrences are in the first 6 months. The potential morbidity of RUTIs is high, especially in infants, the elderly, and pregnant patients. Uropathogenic bacteria reside in the rectal vault, colonize the vagina, and then ascend per the urethra into the bladder. These bacteria avidly adhere to uroepithelial cells using pili and can further ascend to the kidneys. Empiric treatment of an initial uncomplicated UTI is acceptable, but recurrences warrant a urine culture and possible radiographic evaluation. Fluoroquinolones are now first-line medications for UTIs, except in geographic areas where resistance to TMP-SMX is still low. Response to therapy should govern the need for additional treatment. Certain motivated patients with three or more UTIs per year should be considered for prophylaxis therapy.

AB - Urinary tract infections in female patients are exceedingly common. One third of all women with an initial UTI demonstrate recurrence, and one third of those recurrences are in the first 6 months. The potential morbidity of RUTIs is high, especially in infants, the elderly, and pregnant patients. Uropathogenic bacteria reside in the rectal vault, colonize the vagina, and then ascend per the urethra into the bladder. These bacteria avidly adhere to uroepithelial cells using pili and can further ascend to the kidneys. Empiric treatment of an initial uncomplicated UTI is acceptable, but recurrences warrant a urine culture and possible radiographic evaluation. Fluoroquinolones are now first-line medications for UTIs, except in geographic areas where resistance to TMP-SMX is still low. Response to therapy should govern the need for additional treatment. Certain motivated patients with three or more UTIs per year should be considered for prophylaxis therapy.

UR - http://www.scopus.com/inward/record.url?scp=1242314714&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=1242314714&partnerID=8YFLogxK

U2 - 10.1016/S0025-7125(03)00148-2

DO - 10.1016/S0025-7125(03)00148-2

M3 - Review article

VL - 88

SP - 417

EP - 429

JO - Medical Clinics of North America

T2 - Medical Clinics of North America

JF - Medical Clinics of North America

SN - 0025-7125

IS - 2

ER -